EMEA-001680-PIP01-14

Key facts

Invented name
Exforge
Active substance
  • Amlodipine (besylate)
  • valsartan
Therapeutic area
Cardiovascular diseases
Decision number
P/0315/2014
PIP number
EMEA-001680-PIP01-14
Pharmaceutical form(s)
  • Film-coated tablet
  • Orodispersible tablet
Condition(s) / indication(s)
Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Novartis Europharm Ltd. 
United Kingdom 
E-mail: paediatric.enquiries@novartis.com 
Tel. +41 613241111 
Fax +41 613248001
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating